Inactive

FedBizOps Synopsis Document Type: Combined Synopsis/Solicitation Solicitation Number: RFQ-NIAID-2074581 Posted Date: 04/28/2021 Response Date: 05/05/2021 Set Aside: No NAICS Code: 3334516 Classificati... FedBizOps Synopsis Document Type: Combined Synopsis/Solicitation Solicitation Number: RFQ-NIAID-2074581 Posted Date: 04/28/2021 Response Date: 05/05/2021 Set Aside: No NAICS Code: 3334516 Classification Code: 6640 Contracting Office Address: Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 5605 Fishers Lane Ste 3A58, Rockville Md 20892 Primary Point of Contact: Dana Monroe: dana.monroe@nih.gov Description: This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-2074581and the solicitation is issued as a Request for Quotes (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2021-05 March 10, 2021. The North American Industry Classification System (NAICS) code for this procurement is 335516, Analytical Laboratory Instrument Manufacturing with a size standard of 1000 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside. Currently NIH/NIAID is using an HD-1 Analyzer, manufactured and distributed solely by Quanterix corporation, to analyze biomarkers which cannot be measured by conventional ELISA because of concentrations below assay's LLoD, such as serum Nfl. As Quanterix corporation has stopped production, support and maintenance of their HD-1 Analyzer we need to look for another system with analogous sensitivity to measure biomarkers present at low concentrations in patients' body fluids. SR-X Analyzer is another instrument manufactured and distributed solely by Quanterix corporation that uses same technology (single molecular array, SIMOA®) as their HD-1 analyzer, but is smaller (benchtop) and significantly cheaper, both as upfront investment and as yearly maintenance contracts. It requires more user input, but this should not be a problem with our volume of samples. In order to assure continuity of measurements in longitudinal samples from our ongoing clinical protocols, it is essential that we can use kits of coating/detection Abs from the same company. We already generated biomarker data on >1000 CSF/serum samples and continue expanding this through analyses of samples derived from current patients in our clinical protocols. The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for: Quanterix SR-X Ultra-Sensitive Biomarker Detection System, catalog # 102917, 1 EA Installation Kit for SR-X, catalog # 103082, 1 EA Simoa Microplate Washer, catalog # 102897, 1 EA Simoa Microplate Shaker (110V), catalog # 102899, 1 EA SR-X Standard Factory Warranty, 1 EA Basic SR-X Operator Training (3 months access for 1 learner), catalog # 105041, 3 EA On-site Advanced Training, 1 visit up to 3 consecutive days, catalog # 101530, 1 EA Quanterix SRX/SP-X Bundle Shipping, catalog # 103165, 1 EA NOTE: NIAID would like a trade-in consideration for an HD-1 system the lab currently has, S/N 2710000066, to be exchanged at the time the new SRX is delivered. Please quote accordingly. Place of Performance: NIH, 10 Center Drive, BLDG 10 Clinical Center, Bethesda, MD 20852, United States. FOB: Destination The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following; technical capability to meet the requirements and price. The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (JUN 2020) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (FEB 2021) FAR 52.204-7 System for Award Management (OCT 2018) (Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017) 52.204–26 Covered Telecommunications Equipment or Services-Representation (OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26 The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (OCT 2018) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (JAN 2021) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (DEC 2013) FAR 52.204-13 System for Award Management Maintenance (OCT 2018) FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2020) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (DEC 2015) 52.252-2 -- Clauses Incorporated by Reference. (FEB 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. Submission shall be received not later than May 5, 2021 at 5:00pm PDST Offers may be e-mailed to Dana Monroe at dana.monroe@nih.gov. Offers shall include RFQ number in the subject line RFQ-NIAID-2074581. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Dana Monroe at dana.monroe@nih.gov.